Latest Peyronie's disease Stories
CHESTERBROOK, Pa., May 7, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.
1Q 2014 Net Revenues Increased 34% Over 1Q 2013 to $88.5 Million on Acquisition Growth and Launch Momentum for STENDRA and XIAFLEX in Peyronie's Disease CHESTERBROOK, Pa., May 5, 2014 /PRNewswire/
LYNBROOK, N.Y., May 1, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
CHESTERBROOK, Pa., May 1, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.
Company to Report Full 1Q 2014 Financial Results on Monday, May 5 CHESTERBROOK, Pa., April 29, 2014 /PRNewswire/ -- Auxilium
Four Podium Sessions to Highlight New Analyses of Data from Pivotal Phase 3 Trials Evaluating XIAFLEX for the Treatment of Peyronie's Disease CHESTERBROOK, Pa., April 28, 2014 /PRNewswire/
Encore Data Highlighted from Trials Evaluating XIAFLEX, the First and Only FDA Approved Treatment for Peyronie's Disease CHESTERBROOK, Pa.
2014: The Year of Innovation in Men's Health, According to New York Urology Specialists NEW YORK, April 8, 2014 /PRNewswire/ -- Men have lower life expectancy than women.
STOCKHOLM and CHESTERBROOK, Pa., April 7, 2014 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) and
Also in This Edition: Jobs for Writers and Media Industry Blog Posts NEW YORK, April 4, 2014 /PRNewswire/ -- Below are experts from the ProfNet
- Large; stout; burly.